IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranchon, I.
Right arrow Articles by Anderson, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranchon, I.
Right arrow Articles by Anderson, R. E.
(Investigative Ophthalmology and Visual Science. 2001;42:1375-1379.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Systemic Administration of Phenyl-N-tert-Butylnitrone Protects the Retina from Light Damage

Isabelle Ranchon1,2, Sherry Chen1,2, Kathleen Alvarez1,2 and Robert E. Anderson1,2,3

1 From the Departments of Ophthalmology and 3 Cell Biology, University of Oklahoma Health Sciences Center, and the 2 Dean A. McGee Eye Institute, Oklahoma City.

PURPOSE. This study was conducted to test the hypothesis that phenyl-N-tert-butylnitrone (PBN), a spin-trapping agent known to cross the blood–brain barrier and protect the brain from ischemia–reperfusion injury, is incorporated into the retina after intraperitoneal injection and protects photoreceptor cells from the damaging effects of constant visible light.

METHODS. Albino rats were injected intraperitoneally with PBN (aqueous solution) or water, or were not injected, and then were placed in constant light (2700 lux) for 24 hours. The incorporation of PBN into the retina was determined by high-performance liquid chromatography. Electroretinograms (ERGs) were recorded before light treatment and 1 and 15 days after the cessation of exposure to constant light. Eyes were taken for histology at each time point and outer nuclear layer (ONL) thickness determined.

RESULTS. PBN was incorporated into the retina after intraperitoneal injection. Both control (water-injected and uninjected) groups exposed to constant light maintained only 28% of ONL thickness and 20% of retinal function, compared with the unexposed control group. In contrast, the PBN-treated animals maintained 80% of ONL thickness and exhibited 87% of retinal function.

CONCLUSIONS. PBN protects the albino rat retina from the damaging effects of constant light stress. That light-induced and hereditary retinal degenerations share certain morphologic hallmarks and follow a similar apoptotic mechanism of degeneration raises the possibility of pharmacologic therapy for hereditary and environmentally induced neurodegenerative disorders.




This article has been cited by other articles:


Home page
IOVSHome page
R. Maccarone, S. Di Marco, and S. Bisti
Saffron Supplement Maintains Morphology and Function after Exposure to Damaging Light in Mammalian Retina
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1254 - 1261.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. B. Wilson, K. Kunchithapautham, and B. Rohrer
Paradoxical Role of BDNF: BDNF+/- Retinas Are Protected against Light Damage-Mediated Stress
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2877 - 2886.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Samardzija, A. Wenzel, S. Aufenberg, M. Thiersch, C. Reme, and C. Grimm
Differential role of Jak-STAT signaling in retinal degenerations
FASEB J, November 1, 2006; 20(13): 2411 - 2413.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Tomita, Y. Kotake, and R. E. Anderson
Mechanism of Protection from Light-Induced Retinal Degeneration by the Synthetic Antioxidant Phenyl-N-tert-Butylnitrone
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 427 - 434.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Li, W. Cao, and R. E. Anderson
Alleviation of Constant-Light-Induced Photoreceptor Degeneration by Adaptation of Adult Albino Rat to Bright Cyclic Light
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4968 - 4975.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Ranchon, M. M. LaVail, Y. Kotake, and R. E. Anderson
Free Radical Trap Phenyl-N-tert-Butylnitrone Protects against Light Damage But Does Not Rescue P23H and S334ter Rhodopsin Transgenic Rats from Inherited Retinal Degeneration
J. Neurosci., July 9, 2003; 23(14): 6050 - 6057.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Kano, T. Abe, H. Tomita, T. Sakata, S.-i. Ishiguro, and M. Tamai
Protective Effect against Ischemia and Light Damage of Iris Pigment Epithelial Cells Transfected with the BDNF Gene
Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3744 - 3753.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. McBee, J. P. Van Hooser, G.-F. Jang, and K. Palczewski
Isomerization of 11-cis-Retinoids to All-trans-retinoids in Vitro and in Vivo
J. Biol. Chem., December 14, 2001; 276(51): 48483 - 48493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology